Evidence map›Paper›PMID 28877431›Full record

ArticleACS nano2017

In Situ Imaging of Tissue Remodeling with Collagen Hybridizing Peptides.

Jeongmin Hwang, Yufeng Huang, Timothy J Burwell, Norman C Peterson, Jane Connor, Stephen J Weiss, S Michael Yu, Yang Li

Abstract read
In one paragraph

Article in ACS nano, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 115 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
115citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

115 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Molecular Imaging of Collagen Turnover in Myocardial Infarction.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Around the collagen triple helix: an introduction to studying associated genetic and acquired diseases.Matrix biology : journal of the International Society for Matrix Biology · 2025
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

55 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jeongmin Hwang3Helix Inc , Salt Lake City, Utah 84117, United States.ORCID 0000-0001-8799-3209
Yufeng HuangDivision of Nephrology and Hypertension, Department of Internal Medicine, University of Utah School of Medicine , Salt Lake City, Utah 84132, United States.
Timothy J BurwellMedImmune LLC , Gaithersburg, Maryland 20878, United States.
Norman C PetersonMedImmune LLC , Gaithersburg, Maryland 20878, United States.
Jane ConnorMedImmune LLC , Gaithersburg, Maryland 20878, United States.
Stephen J WeissDivision of Molecular Medicine & Genetics, Department of Internal Medicine, and the Life Sciences Institute, University of Michigan , Ann Arbor, Michigan 48109, United States.
S Michael Yu3Helix Inc , Salt Lake City, Utah 84117, United States.ORCID 0000-0002-5171-2644
Yang Li3Helix Inc , Salt Lake City, Utah 84117, United States.ORCID 0000-0003-4729-7860

Funding

FUNCTION OF THE MEMBRANE TYPE MATRIX METALLOPROTEINASER01CA071699 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI WEISS, STEPHEN J · 1997 to 2024
$7.3M
Study and Application of Collagen Mimetic Peptide-Collagen HybridizationR01AR060484 · NIAMS · UNIVERSITY OF UTAH · PI YU, MICHAEL S · 2011 to 2015
$1.7M
Collagen-Targeted Therapeutics of Cathepsin InhibitorsR21AR065124 · NIAMS · UNIVERSITY OF UTAH · PI YU, MICHAEL S · 2014 to 2015
$381k
New Peptide Reagent for Imaging Denatured Collagen in HistopathologyR43OD021986 · OD · 3HELIX, INC. · PI LI, YANG · 2016 to 2016
$150k
NCI NIH HHS R01 CA071699NIAMS NIH HHS R01 AR060484NIAMS NIH HHS R21 AR065124NIH HHS R43 OD021986
6 · The paper itself

Abstract

Collagen, the major structural component of nearly all mammalian tissues, undergoes extensive proteolytic remodeling during developmental states and a variety of life-threatening diseases such as cancer, myocardial infarction, and fibrosis. While degraded collagen could be an important marker of tissue damage, it is difficult to detect and target using conventional tools. Here, we show that a designed peptide (collagen hybridizing peptide: CHP), which specifically hybridizes to the degraded, unfolded collagen chains, can be used to image degraded collagen and inform tissue remodeling activity in various tissues: labeled with 5-carboxyfluorescein and biotin, CHPs enabled direct localization and quantification of collagen degradation in isolated tissues within pathologic states ranging from osteoarthritis and myocardial infarction to glomerulonephritis and pulmonary fibrosis, as well as in normal tissues during developmental programs associated with embryonic bone formation and skin aging. The results indicate the general correlation between the level of collagen remodeling and the amount of denatured collagen in tissue and show that the CHP probes can be used across species and collagen types, providing a versatile tool for not only pathology and developmental biology research but also histology-based disease diagnosis, staging, and therapeutic screening. This study lays the foundation for further testing CHP as a targeting moiety for theranostic delivery in various animal models.

Indexed as

Bone RemodelingAgedAnimalsCollagenGlomerulonephritisHumansMaleMiceMice, Inbred C57BLMyocardial InfarctionOsteoarthritisPeptidesPulmonary FibrosisSwineCollagenPeptidesbone formationfibrosisinflammationmatrix metalloproteinasetargeted deliverytriple helix

Identifiers

PMID28877431
PMCPMC5656977

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.